Skip to content
TrialScanner

NCT04614467

A Placebo-Controlled Trial of CLBS16 in Subjects With Coronary Microvascular Dysfunction

Phase 2TerminatedLSTALead

Registry record

Lead sponsor
Lisata Therapeutics, Inc.
Conditions
Coronary Microvascular Dysfunction; Coronary Microvascular Disease; Microvascular Coronary Artery Disease
Primary completion
Sep 28, 2022Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT04614467 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT04614467: A Placebo-Controlled Trial... | TrialScanner